An Era of Therapeutic Evolution and Revolution: Insights into Studies on Dupilumab, Tralokinumab, Lebrikizumab, Nemolizumab, Eblasakimab, and OX40/OX40L Agents (Rocatinlimab and Amlitelimab) in Moderate-to-Severe Atopic Dermatitis

<p id="p1">Atopic dermatitis (AD), a prevalent chronic inflammatory skin condition, presents with diverse phenotypes and endotypes. Traditional treatments have included topical corticosteroids, phototherapy, calcineurin inhibitors, and systemic immunosuppressants, the latter often necessitating freq...

Descripción completa

Detalles Bibliográficos

Autores principales:	Skayem, Charbel, Duong, Tu Anh
Formato:	Capítulo de libro
Lenguaje:	inglés
Publicado:	IntechOpen 2024
Materias:	Health Sciences
Acceso en línea:	https://www.intechopen.com/chapters/1170522
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!